These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38378385)

  • 41. Artificial intelligence in drug discovery: recent advances and future perspectives.
    Jiménez-Luna J; Grisoni F; Weskamp N; Schneider G
    Expert Opin Drug Discov; 2021 Sep; 16(9):949-959. PubMed ID: 33779453
    [No Abstract]   [Full Text] [Related]  

  • 42. Trends in Deep Learning for Property-driven Drug Design.
    Born J; Manica M
    Curr Med Chem; 2021; 28(38):7862-7886. PubMed ID: 34325627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intelligently Applying Artificial Intelligence in Chemoinformatics.
    Sharma S; Sharma D
    Curr Top Med Chem; 2018; 18(20):1804-1826. PubMed ID: 30465503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Artificial Intelligence (AI) in Drugs and Pharmaceuticals.
    Sahu A; Mishra J; Kushwaha N
    Comb Chem High Throughput Screen; 2022; 25(11):1818-1837. PubMed ID: 34875986
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Machine learning approaches and their applications in drug discovery and design.
    Priya S; Tripathi G; Singh DB; Jain P; Kumar A
    Chem Biol Drug Des; 2022 Jul; 100(1):136-153. PubMed ID: 35426249
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 2: a discussion of chemical and biological data.
    Bender A; Cortes-Ciriano I
    Drug Discov Today; 2021 Apr; 26(4):1040-1052. PubMed ID: 33508423
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.
    Yang X; Wang Y; Byrne R; Schneider G; Yang S
    Chem Rev; 2019 Sep; 119(18):10520-10594. PubMed ID: 31294972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Automated and enabling technologies for medicinal chemistry.
    Nichols PL
    Prog Med Chem; 2021; 60():191-272. PubMed ID: 34147203
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Artificial intelligence for compound pharmacokinetics prediction.
    Obrezanova O
    Curr Opin Struct Biol; 2023 Apr; 79():102546. PubMed ID: 36804676
    [TBL] [Abstract][Full Text] [Related]  

  • 50. From computer-aided drug discovery to computer-driven drug discovery.
    Frye L; Bhat S; Akinsanya K; Abel R
    Drug Discov Today Technol; 2021 Dec; 39():111-117. PubMed ID: 34906321
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Accelerating COVID-19 Drug Discovery with High-Performance Computing.
    Heifetz A
    Methods Mol Biol; 2024; 2716():405-411. PubMed ID: 37702951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: Molecular
    Lin E; Lin CH; Lane HY
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32708785
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent applications of artificial intelligence in RNA-targeted small molecule drug discovery.
    Morishita EC; Nakamura S
    Expert Opin Drug Discov; 2024 Apr; 19(4):415-431. PubMed ID: 38321848
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Artificial intelligence in small molecule drug discovery from 2018 to 2023: Does it really work?
    Lv Q; Zhou F; Liu X; Zhi L
    Bioorg Chem; 2023 Dec; 141():106894. PubMed ID: 37776682
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Closed-loop discovery platform integration is needed for artificial intelligence to make an impact in drug discovery.
    Saikin SK; Kreisbeck C; Sheberla D; Becker JS; A AG
    Expert Opin Drug Discov; 2019 Jan; 14(1):1-4. PubMed ID: 30488727
    [No Abstract]   [Full Text] [Related]  

  • 56. Computational Chemistry in Structure-Based Solute Carrier Transporter Drug Design: Recent Advances and Future Perspectives.
    Tu G; Fu T; Zheng G; Xu B; Gou R; Luo D; Wang P; Xue W
    J Chem Inf Model; 2024 Mar; 64(5):1433-1455. PubMed ID: 38294194
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Applications of artificial intelligence to drug design and discovery in the big data era: a comprehensive review.
    Tripathi N; Goshisht MK; Sahu SK; Arora C
    Mol Divers; 2021 Aug; 25(3):1643-1664. PubMed ID: 34110579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Artificial intelligence-guided discovery of anticancer lead compounds from plants and associated microorganisms.
    Li G; Lin P; Wang K; Gu CC; Kusari S
    Trends Cancer; 2022 Jan; 8(1):65-80. PubMed ID: 34750090
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Next generation human skin constructs as advanced tools for drug development.
    Abaci HE; Guo Z; Doucet Y; Jacków J; Christiano A
    Exp Biol Med (Maywood); 2017 Nov; 242(17):1657-1668. PubMed ID: 28592171
    [TBL] [Abstract][Full Text] [Related]  

  • 60. De novo molecular design and generative models.
    Meyers J; Fabian B; Brown N
    Drug Discov Today; 2021 Nov; 26(11):2707-2715. PubMed ID: 34082136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.